Validation of the French national health insurance information system as a tool in vaccine safety assessment: application to febrile convulsions after pediatric measles/mumps/rubella immunization.

[1]  Sheila Davey,et al.  State of the world's vaccines and immunization , 2013 .

[2]  S. Ozawa,et al.  Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review. , 2012, Vaccine.

[3]  A. Weill,et al.  French national health insurance information system and the permanent beneficiaries sample. , 2010, Revue d'epidemiologie et de sante publique.

[4]  M. Gold,et al.  Use of the Australian Childhood Immunisation Register for vaccine safety data linkage. , 2010, Vaccine.

[5]  B. Bégaud,et al.  Pharmacoepidemiological research using French reimbursement databases: yes we can! , 2010, Pharmacoepidemiology and drug safety.

[6]  N. Andrews,et al.  Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom. , 2007, American journal of epidemiology.

[7]  J. Olsen,et al.  MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis. , 2004, JAMA.

[8]  P. Duclos.  A global perspective on vaccine safety. , 2004, Vaccine.

[9]  T. Jefferson,et al.  Unintended events following immunization with MMR: a systematic review. , 2003, Vaccine.

[10]  Robert T. Chen,et al.  Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines , 2003, Expert review of vaccines.

[11]  John W. Glasser,et al.  The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. , 2001, The New England journal of medicine.

[12]  V. Pankratz,et al.  Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study. , 2001, Vaccine.

[13]  John W. Glasser,et al.  Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. , 1997, Pediatrics.

[14]  S. Rosenthal,et al.  The reporting sensitivities of two passive surveillance systems for vaccine adverse events. , 1995, American journal of public health.

[15]  A. Colville,et al.  A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines , 1995, The Lancet.

[16]  A. Colville,et al.  Risk of aseptic meningitis after measles, mumps,and rubella vaccine in UK children , 1993, The Lancet.

[17]  N. Begg,et al.  Role of epidemiology in vaccine policy. , 1990, Vaccine.

[18]  D. Levy-bruhl,et al.  Vaccination coverage estimated based on data found in 24th month health certificates of infants, France, 2004-2007. , 2010 .